| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-PD-1 antibody-activated Th17 cells subvert re-invigoration of antitumor cytotoxic T-lymphocytes via myeloid cell-derived COX-2/PGE2
|
Li, Qingsheng
|
|
|
72 |
4 |
p. 1047-1058
|
artikel
|
| 2 |
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
|
Español-Rego, Marta
|
|
|
72 |
4 |
p. 827-840
|
artikel
|
| 3 |
Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
|
Guo, Wei
|
|
|
72 |
4 |
p. 1029-1045
|
artikel
|
| 4 |
Correction to: Anti‑PD‑1 antibody‑activated Th17 cells subvert re‑invigoration of antitumor cytotoxic T‑lymphocytes via myeloid cell‑derived COX‑2/PGE2
|
Li, Qingsheng
|
|
|
72 |
4 |
p. 1059
|
artikel
|
| 5 |
Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
|
Weber, Jeffrey S.
|
|
|
72 |
4 |
p. 955
|
artikel
|
| 6 |
Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer
|
Li, Ke
|
|
|
72 |
4 |
p. 917-928
|
artikel
|
| 7 |
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma
|
Fukuokaya, Wataru
|
|
|
72 |
4 |
p. 841-849
|
artikel
|
| 8 |
Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy
|
Okita, Riki
|
|
|
72 |
4 |
p. 865-879
|
artikel
|
| 9 |
Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activities
|
Lu, Zhen
|
|
|
72 |
4 |
p. 815-826
|
artikel
|
| 10 |
Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
|
Beelen, Nicky A.
|
|
|
72 |
4 |
p. 797-804
|
artikel
|
| 11 |
Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
|
Jo, Tatsuro
|
|
|
72 |
4 |
p. 929-944
|
artikel
|
| 12 |
Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
|
Owen, Kathryn
|
|
|
72 |
4 |
p. 805-814
|
artikel
|
| 13 |
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
|
Weber, Jeffrey S.
|
|
|
72 |
4 |
p. 945-954
|
artikel
|
| 14 |
Pancreatic involvement due to immune checkpoint inhibitors: a proposed classification
|
Ashkar, Motaz
|
|
|
72 |
4 |
p. 895-901
|
artikel
|
| 15 |
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma
|
Mocan, Lavinia Patricia
|
|
|
72 |
4 |
p. 1003-1014
|
artikel
|
| 16 |
Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer
|
Shi, Ranran
|
|
|
72 |
4 |
p. 985-1001
|
artikel
|
| 17 |
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma
|
Liu, Jianhua
|
|
|
72 |
4 |
p. 881-893
|
artikel
|
| 18 |
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement
|
Suematsu, Masaya
|
|
|
72 |
4 |
p. 957-968
|
artikel
|
| 19 |
Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function
|
Ping, Yu
|
|
|
72 |
4 |
p. 1015-1027
|
artikel
|
| 20 |
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer
|
Kajihara, Nabeel
|
|
|
72 |
4 |
p. 851-864
|
artikel
|
| 21 |
αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade
|
Pan, Mingzhu
|
|
|
72 |
4 |
p. 969-984
|
artikel
|
| 22 |
ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth
|
Li, Jing
|
|
|
72 |
4 |
p. 903-916
|
artikel
|
Tijdschrift beschrijving